NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-298 Cr | ₹-150 Cr | ₹-61 Cr | ₹-96 Cr | ₹-84 Cr |
What is the latest Cash Flow from Investing Activities ratio of NEULAND LABORATORIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2025 | ₹-298 Cr |
Mar2024 | ₹-150 Cr |
Mar2023 | ₹-61 Cr |
Mar2022 | ₹-96 Cr |
Mar2021 | ₹-84 Cr |
How is Cash Flow from Investing Activities of NEULAND LABORATORIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-298 Cr | Negative | |
Mar2024 | ₹-150 Cr | Negative | |
Mar2023 | ₹-61 Cr | Negative | |
Mar2022 | ₹-96 Cr | Negative | |
Mar2021 | ₹-84 Cr | - |
Compare Cash Flow from Investing Activities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹18,431.6 Cr | 21% | 14.8% | 89% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 21% |
14.8% |
89% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses